Related references
Note: Only part of the references are listed.The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis
Kevin T. Bush et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes
Wei Wu et al.
SCIENTIFIC REPORTS (2017)
Determination of Human Hepatic CYP2C8 and CYP1A2 Age-Dependent Expression to Support Human Health Risk Assessment for Early Ages
Gina Song et al.
DRUG METABOLISM AND DISPOSITION (2017)
Drug Metabolism in the Liver
Omar Abdulhameed Almazroo et al.
CLINICS IN LIVER DISEASE (2017)
Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
Miriam G. Mooij et al.
CLINICAL PHARMACOKINETICS (2016)
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics
B. Prasad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy
Frederique Rodieux et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
Nikki Mulligan et al.
FRONTIERS IN PHARMACOLOGY (2016)
Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approachs
Henry C. Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Kidney versus Liver Specification of SLC and ABC Drug Transporters, Tight Junction Molecules, and Biomarkers
Gleb Martovetsky et al.
DRUG METABOLISM AND DISPOSITION (2016)
Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters
Sanjay K. Nigam et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group
K. L. R. Brouwer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
THE ORGANIC ANION TRANSPORTER (OAT) FAMILY: A SYSTEMS BIOLOGY PERSPECTIVE
Sanjay K. Nigam et al.
PHYSIOLOGICAL REVIEWS (2015)
What do drug transporters really do?
Sanjay K. Nigam
NATURE REVIEWS DRUG DISCOVERY (2015)
Predicting the First dose in children of CYP3A-metabolized drugs: Evaluation of scaling approaches and insights into the CYP3A7-CYP3A4 switch at young ages
Ashley Strougo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin
Ligong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
Maria Johansson et al.
FRONTIERS IN GENETICS (2014)
Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
A. R. Maharaj et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Organic Cation Transporter 3 (OCT3/SLC22A3) and Multidrug and Toxin Extrusion 1 (MATE1/SLC47A1) Transporter in the Placenta and Fetal Tissues: Expression Profile and Fetus Protective Role at Different Stages of Gestation
Davoud Ahmadimoghaddam et al.
BIOLOGY OF REPRODUCTION (2013)
The Integration of Allometry and Virtual Populations to Predict Clearance and Clearance Variability in Pediatric Populations over the Age of 6 Years
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2013)
Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations
Ibrahim Ince et al.
CLINICAL PHARMACOKINETICS (2013)
How Much Do We Know About Drug Handling by SLC and ABC Drug Transporters in Children?
S. K. Nigam et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Hepatocyte Nuclear Factors 4α and 1α Regulate Kidney Developmental Expression of Drug-Metabolizing Enzymes and Drug Transporters
Gleb Martovetsky et al.
MOLECULAR PHARMACOLOGY (2013)
Multispecific Drug Transporter Slc22a8 (Oat3) Regulates Multiple Metabolic and Signaling Pathways
Wei Wu et al.
DRUG METABOLISM AND DISPOSITION (2013)
Ontogeny of Hepatic Glucuronidation; Methods and Results
Elke H.J. Krekels et al.
CURRENT DRUG METABOLISM (2012)
Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult Mice
Jessica A. Bonzo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Organic Anion and Cation SLC22 Drug'' Transporter (Oat1, Oat3, and Oct1) Regulation during Development and Maturation of the Kidney Proximal Tubule
Thomas F. Gallegos et al.
PLOS ONE (2012)
Ontogeny of Novel Cytochrome P450 Gene Isoforms during Postnatal Liver Maturation in Mice
Julia Yue Cui et al.
DRUG METABOLISM AND DISPOSITION (2012)
Steady-State Pharmacokinetics of Tenofovir-Based Regimens in HIV-Infected Pediatric Patients
Jennifer R. King et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Analysis of Three-dimensional Systems for Developing and Mature Kidneys Clarifies the Role of OAT1 and OAT3 in Antiviral Handling
Megha A. Nagle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Untargeted Metabolomics Identifies Enterobiome Metabolites and Putative Uremic Toxins as Substrates of Organic Anion Transporter 1 (Oat1)
William R. Wikoff et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Remote Communication through Solute Carriers and ATP Binding Cassette Drug Transporter Pathways: An Update on the Remote Sensing and Signaling Hypothesis
Wei Wu et al.
MOLECULAR PHARMACOLOGY (2011)
Functional Maturation of Drug Transporters in the Developing, Neonatal, and Postnatal Kidney
Derina E. Sweeney et al.
MOLECULAR PHARMACOLOGY (2011)
Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR
Antonia H. Tolson et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Nonrenal Drug Clearance in CKD: Searching for the Path Less Traveled
Jeremiah D. Momper et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2010)
Protein kinase A regulates GDNF/RET-dependent but not GDNF/Ret-independent ureteric bud outgrowth from the Wolffian duct
James B. Tee et al.
DEVELOPMENTAL BIOLOGY (2010)
Organogenesis and Development of the Liver
Karim Si-Tayeb et al.
DEVELOPMENTAL CELL (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
How Does the Ureteric Bud Branch?
Sanjay K. Nigam et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Hnf1α (MODY3) Controls Tissue-Specific Transcriptional Programs and Exerts Opposed Effects on Cell Growth in Pancreatic Islets and Liver
Joan-Marc Servitja et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Toward a Systems Level Understanding of Organic Anion and Other Multispecific Drug Transporters: A Remote Sensing and Signaling Hypothesis
Sun-Young Ahn et al.
MOLECULAR PHARMACOLOGY (2009)
Regulation of the CYP3A4 and CYP3A7 Promoters by Members of the Nuclear Factor I Transcription Factor Family
Amanda K. Riffel et al.
MOLECULAR PHARMACOLOGY (2009)
Identification of an Endogenous Ligand Bound to a Native Orphan Nuclear Receptor
Xiaohui Yuan et al.
PLOS ONE (2009)
Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination
David M. Truong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Organic anion transporter 3 (Oat3/Slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin
Adam L. VanWert et al.
MOLECULAR PHARMACOLOGY (2008)
Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice
Andrew J. Lickteig et al.
LIFE SCIENCES (2008)
Analysis of Metagene Portraits Reveals Distinct Transitions During Kidney Organogenesis
Igor F. Tsigelny et al.
SCIENCE SIGNALING (2008)
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs - Potential remote sensing by oat family members
Gregory Kaler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The chloride dependence of the human organic anion transporter 1 (hOAT1) is blunted by mutation of a single amino acid
Ahsan N. Rizwan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir
Tomoki Imaoka et al.
MOLECULAR PHARMACOLOGY (2007)
Ontogeny of human hepatic cytochromes P450
Ronald N. Hines
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2007)
Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3)
Vibha Bhatnagar et al.
JOURNAL OF HUMAN GENETICS (2006)
Integration of hepatic drug transporters and phase II metabolizing enzymes: Mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites
MJ Zamek-Gliszczynski et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models
DH Sweet et al.
KIDNEY INTERNATIONAL (2006)
Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice
SA Eraly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The impact of plasma protein binding on the renal transport of organic anions
DAJ Bow et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)] -: Rapid Communication
G Xu et al.
KIDNEY INTERNATIONAL (2005)
Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (MRP) family in mice
JM Maher et al.
DRUG METABOLISM AND DISPOSITION (2005)
Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney
DL Steer et al.
DEVELOPMENTAL BIOLOGY (2004)
Molecular and cellular physiology of renal organic cation and anion transport
SH Wright et al.
PHYSIOLOGICAL REVIEWS (2004)
Kidney CYP450 enzymes: Biological actions beyond drug metabolism
X Zhao et al.
CURRENT DRUG METABOLISM (2003)
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2002)
The ontogeny of human drug-metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms
DG McCarver et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Changes in global gene expression patterns during development and maturation of the rat kidney
RO Stuart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Developmentally regulated expression of organic ion transporters NKT(OAT1), OCT1, NLT(OAT2), and Roct
A Pavlova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2000)
Share Paper
